Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised, double-blind, placebo-controlled study of APD421 (IV amisulpride) for treatment of post-operative nausea and vomiting
2015-002041-59Phase 3Completed
- Sponsor
- Acacia Pharma Group Plc
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of amisulpride in Nausea and Vomiting and nausea ((none)) (3 arms), sponsored by Acacia Pharma Group Plc. Primary endpoint: Success in primary PONV treatment. Started Jun 2015; status: completed.
02
Drugs
amisulpride
03
Conditions
Nausea and Vomitingnausea ((none))
Beyond the preview
Go deeper on 2015-002041-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002041-59.